These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38746200)

  • 1. RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis
    Banerjee S; Onwunyi VRC; Hong J; Martineau S; Fishbein GA; Bonnet SB; Provencher S; Bonnet S; Umar S
    bioRxiv; 2024 May; ():. PubMed ID: 38746200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure.
    Banerjee S; Hong J; Umar S
    Front Cardiovasc Med; 2022; 9():935423. PubMed ID: 36158812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Rate Reduction Improves Right Ventricular Function and Fibrosis in Pulmonary Hypertension.
    Ishii R; Okumura K; Akazawa Y; Malhi M; Ebata R; Sun M; Fujioka T; Kato H; Honjo O; Kabir G; Kuebler WM; Connelly K; Maynes JT; Friedberg MK
    Am J Respir Cell Mol Biol; 2020 Dec; 63(6):843-855. PubMed ID: 32915674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
    Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
    Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension.
    Nadadur RD; Umar S; Wong G; Eghbali M; Iorga A; Matori H; Partow-Navid R; Eghbali M
    J Appl Physiol (1985); 2012 Jul; 113(1):149-58. PubMed ID: 22628376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.
    Steppan J; Wang H; Nandakumar K; Gadkari M; Poe A; Pak L; Brady T; Berkowitz DE; Shimoda LA; Santhanam L
    Am J Physiol Lung Cell Mol Physiol; 2024 Oct; 327(4):L423-L438. PubMed ID: 39010824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
    Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
    Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension.
    Umar S; Lee JH; de Lange E; Iorga A; Partow-Navid R; Bapat A; van der Laarse A; Saggar R; Saggar R; Ypey DL; Karagueuzian HS; Eghbali M
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):181-90. PubMed ID: 22199010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketone bodies in right ventricular failure: A unique therapeutic opportunity.
    Blake M; Puchalska P; Kazmirczak F; Blake J; Moon R; Thenappan T; Crawford PA; Prins KW
    Heliyon; 2023 Nov; 9(11):e22227. PubMed ID: 38058654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.
    Steppan J; Wang H; Nandakumar K; Poe A; Pak L; Brady T; Gadkari M; Berkowitz DE; Shimoda LA; Santhanam L
    bioRxiv; 2023 Oct; ():. PubMed ID: 37961202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
    Yu M; Peng L; Liu P; Yang M; Zhou H; Ding Y; Wang J; Huang W; Tan Q; Wang Y; Xie W; Kong H; Wang H
    Drug Des Devel Ther; 2020; 14():1191-1202. PubMed ID: 32256050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension.
    Neto-Neves EM; Frump AL; Vayl A; Kline JA; Lahm T
    Physiol Rep; 2017 Oct; 5(19):. PubMed ID: 29038355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure.
    Hautbergue T; Antigny F; Boët A; Haddad F; Masson B; Lambert M; Delaporte A; Menager JB; Savale L; Pavec JL; Fadel E; Humbert M; Junot C; Fenaille F; Colsch B; Mercier O
    Cells; 2021 Jun; 10(6):. PubMed ID: 34205639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
    Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.
    Frump AL; Goss KN; Vayl A; Albrecht M; Fisher A; Tursunova R; Fierst J; Whitson J; Cucci AR; Brown MB; Lahm T
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L873-90. PubMed ID: 25713318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy.
    Umar S; Partow-Navid R; Ruffenach G; Iorga A; Moazeni S; Eghbali M
    Biol Sex Differ; 2017; 8():9. PubMed ID: 28344760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
    Comarița IK; Tanko G; Anghelache IL; Georgescu A
    J Transl Med; 2024 Feb; 22(1):137. PubMed ID: 38317144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.